top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Hospital-Based Health Technology Assessment : The Next Frontier for Health Technology Assessment / / edited by Laura Sampietro-Colom, Janet Martin
Hospital-Based Health Technology Assessment : The Next Frontier for Health Technology Assessment / / edited by Laura Sampietro-Colom, Janet Martin
Edizione [1st ed. 2016.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Adis, , 2016
Descrizione fisica 1 online resource (384 pages) : color illustrations
Disciplina 362.1
Soggetto topico Pharmacy management
Medical research
Health informatics
Pharmacoeconomics and Health Outcomes
Quality of Life Research
Health Informatics
ISBN 3-319-39205-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto 1. Introduction -- 2. Hospital-Based Health Technology Assessment: The Australian Experience -- 3. Hospital-Based HTA in China -- 4. Hospital-Based Health Technology Assessment (HTA) in New Zealand -- 5. Hospital-Based Health Technology Assessment in a Public-Sector Tertiary Hospital In Singapore -- 6. Hospital Based Health Technology Assessment In Denmark -- 7. Health Technology Assessment Activities in Finnish Hospitals -- 8. The ComitéD´Evaluationet de Diffusion des Technologiques  (CEDIT) -- 9. The HTA and Innovation Unit at Gemelli University Hospital -- 10. Hospital Based HTA at Radboud University Medical Centre in the Netherlands: Welcome to Reality -- 11. Hospital Based Health Technology Assessment in Three Spanish Hospitals -- 12. Activity-Based HTA: Hospital-Based HTA Performed by Clinicians With Support and Quality Control – The Sahlgrenska University Hospital HTA-Centrum Experience -- 13. Hospital HTA in Switzerland -- 14. Hospital Based HTA in Turkey -- 15. The Evidence Decision Support Program (EDSP) within the Surgery Strategic Clinical Network (SSCN) of Alberta Health Services (AHS) -- 16. Hospital HTA and Know4Go at MEDICI in London, Ontario -- 17. Technology Assessment At Sick Kids (TASK): A Health Technology Assessment Research Unit Devoted to Child Health -- 18. Hospitalbased HTA at the Centre hospitalier de l’Université de Montréal -- 19. CHU de Québec – Université Laval: 10 Years Experience in HB-HTA -- 20. CHUS in Quebec -- 21. The Health Technology Assessment Unit (TAU) of the McGill University Health Centre (MUHC) -- 22. The Penn Medicine Center for Evidence-Based Practice: Supporting the Quality, Safety and Value of Patient Care Through Evidence-Based Practice at the Systems Level -- 23. Medical Technology Assessment at Kaiser Permanente -- 24. Health Technology Assessment in aPublic Hospital in South Africa -- 25. Hospital Based HTA in Argentina: The Hospital Garrahanand Hospital El CruceExperience -- 26. The Role of Hospitals in Health Technology Assessment in Brazil -- 27. Networks In HB-HTA -- 28. View from Hospital Stake-Holders -- 29. View From Industry -- 30. Involving Patients In Hospital-Based HTA: Experiences, Approaches And Future Directions -- 31. View from Clinicians -- 32. Hospital Based HTA in 25 Organizations World-Wide: Lessons Learned -- 33. Looking to the Future of HB-HTA: The Next Frontier.
Record Nr. UNINA-9910163047203321
Cham : , : Springer International Publishing : , : Imprint : Adis, , 2016
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Leading Pharmaceutical Innovation : How to Win the Life Science Race / / by Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer
Leading Pharmaceutical Innovation : How to Win the Life Science Race / / by Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer
Autore Gassmann Oliver
Edizione [3rd ed. 2018.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018
Descrizione fisica 1 online resource (XV, 179 p. 41 illus., 3 illus. in color.)
Disciplina 658.514
Soggetto topico Management
Industrial management
Pharmaceutical technology
Pharmacy management
Pharmacy
Health care management
Health services administration
Health economics
Innovation/Technology Management
Pharmaceutical Sciences/Technology
Pharmacoeconomics and Health Outcomes
Health Care Management
Health Economics
ISBN 3-319-66833-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Innovation: Key to Success in the Pharmaceutical Industry -- The Industry Challenge: Who Would Want to Be in This Business?- The Science and Technology Challenge: How to Find New Drugs -- The Pipeline Challenge: How to Organize Innovation -- The Make-or-Buy Challenge: How to In- and Outsource Innovation -- The Open Innovation Challenge: How to Partner for Innovation -- The Internationalization Challenge: Where to Access Innovation -- Future Directions and Trends.
Record Nr. UNINA-9910298214803321
Gassmann Oliver  
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Life in Pain : Affective Economy and the Demand for Pain Relief / / by John L. Fitzgerald
Life in Pain : Affective Economy and the Demand for Pain Relief / / by John L. Fitzgerald
Autore Fitzgerald John L
Edizione [1st ed. 2020.]
Pubbl/distr/stampa Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020
Descrizione fisica 1 online resource (XIII, 195 p. 18 illus., 14 illus. in color.)
Disciplina 306.461
Soggetto topico Medical anthropology
Pain medicine
Crime—Sociological aspects
Pharmacy management
Social policy
Cultural studies
Medical Anthropology
Pain Medicine
Crime and Society
Pharmacoeconomics and Health Outcomes
Social Policy
Cultural Studies
ISBN 981-10-5640-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1: Introduction -- Chapter 2: The extended pain neuromatrix -- Chapter 3: Oxycodone epidemic -- Chapter 4: Global cannabis markets -- Chapter 5: Over-the-counter (OTC) consumers over a barrel -- Chapter 6: Affective economy -- Chapter 7: Reconceptualising the demand for pain relief -- Chapter 8: Regulating pain, regulating drug markets and harm reduction -- Chapter 9: Conclusion.
Record Nr. UNINA-9910370058803321
Fitzgerald John L  
Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Multi-Criteria Decision Analysis to Support Healthcare Decisions / / edited by Kevin Marsh, Mireille Goetghebeur, Praveen Thokala, Rob Baltussen
Multi-Criteria Decision Analysis to Support Healthcare Decisions / / edited by Kevin Marsh, Mireille Goetghebeur, Praveen Thokala, Rob Baltussen
Edizione [1st ed. 2017.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Descrizione fisica 1 online resource (VI, 329 p. 34 illus., 14 illus. in color.)
Disciplina 613
614.44
Soggetto topico Health promotion
Pharmacy management
Health Promotion and Disease Prevention
Pharmacoeconomics and Health Outcomes
ISBN 3-319-47540-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto 1. Introduction -- 2. Theoretical Foundations of Multi-Criteria Decision Analysis -- 3. Identifying Value-s: A Reflection on the Ethical Aspects of MCDA in Healthcare Decisionmaking -- 4. Incorporating Preferences and Priorities into MCDA: Selecting an Appropriate Scoring and Weighting Technique -- 5. Dealing with Uncertainty in the Analysis and Reporting of MCDA -- 6. Supporting the Project Portfolio Selection Decision of Research and Development Investments by Means of Multi-Criteria Resource Allocation Modelling -- 7. Benefit-Risk Assessment -- 8. Advancing MCDA and HTA into Coverage Decision-Making -- 9. Embedding MCDA in Priority Setting Policy Processes – Experiences from Low and Middle Income Countries -- 10. MCDA for Resource Allocation at a Local Level: an Application in the UK -- 11. Shared Decision Making -- 12. The Role of Multi-Criteria Decision Analysis (MCDA) in Health Research Priority Setting -- 13. MCDA for the Development of Clinical Practice Guidelines and for the Prioritization Clinical Research Questions -- 14. Using MCDA as a Decision aid in Health Technology Appraisal for Coverage Decisions: Opportunities, Challenges and Unresolved Questions -- 15. Beyond Value Function Methods in Multi-Criteria Decision Analysis for Health care -- 16. Best Practice for MCDA in Healthcare.
Record Nr. UNINA-9910254478003321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The New Drug Reimbursement Game : A Regulator’s Guide to Playing and Winning / / by Brita A.K. Pekarsky
The New Drug Reimbursement Game : A Regulator’s Guide to Playing and Winning / / by Brita A.K. Pekarsky
Autore Pekarsky Brita A.K
Edizione [1st ed. 2015.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015
Descrizione fisica 1 online resource (256 p.)
Disciplina 610
615.1
615.19
Soggetto topico Pharmacy management
Pharmaceutical technology
Pharmacoeconomics and Health Outcomes
Pharmaceutical Sciences/Technology
ISBN 3-319-08903-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Introduction -- Reframing the political economy of new drugs -- The social rate of return on investment in pharmaceutical R&D -- The value of innovation -- The shadow price -- The health shadow price -- The health shadow price and the economic context -- The `pharmaceutical R&D financing' game -- The `pharmacotherapy needs a premium' game -- Conclusion.
Record Nr. UNINA-9910300196803321
Pekarsky Brita A.K  
Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Patient Involvement in Health Technology Assessment / / edited by Karen M. Facey, Helle Ploug Hansen, Ann N.V. Single
Patient Involvement in Health Technology Assessment / / edited by Karen M. Facey, Helle Ploug Hansen, Ann N.V. Single
Edizione [1st ed. 2017.]
Pubbl/distr/stampa Singapore : , : Springer Singapore : , : Imprint : Adis, , 2017
Descrizione fisica 1 online resource (XXVI, 434 p. 20 illus., 15 illus. in color.)
Disciplina 615.1
Soggetto topico Pharmacy management
Public policy
Pharmacoeconomics and Health Outcomes
Public Policy
ISBN 981-10-4068-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto 1. Health Technology Assessment -- 2. Exploring Ethical Rationales -- 3. Reflections on Terms, Goals and Organisation -- 4. Patient-Based Evidence in HTA -- 5. Developing the Mosaic of Patient Participation in HTA -- 6. Patient Input to HTA -- 7. Discussion - Attending to Values and Quality of Patient Involvement in HTA -- 8. Patients as Collaborative Partners in Clinical Research to Inform HTA -- 9. Developing Patient-Reported and Relevant Outcome Measures -- 10. Discrete Choice Experiments -- 11. Analytic Hierarchy Process -- 12. Ethnographic Fieldwork -- 14. Deliberative Methods to Involve Patients in HTA -- 15. Qualitative Evidence Synthesis -- 16. Evaluation of Patient Involvement in HTA -- 17. Discussion - Making Sense of Patients’ Perspectives, Experiences and Preferences in HTA -- 18. Discussion - Research to promote patient-based HTA -- 19. Australia -- 20. Brazil -- 21. Canada -- 22. Denmark -- 23. England -- 24. EUnetHTA – Patients’ Perspectives in the HTA Core Model® -- 25. Germany -- 26. Italy -- 27. Scotland -- 28. Sweden -- 29. Taiwan -- 30. USA - Comparative Effectiveness Research -- 31. Discussion of Approaches in Different Countries -- 32. Discussion – Patient Participation in HTA; Evidence of Real Change? -- 33. Patient Involvement in Medicine Development and Assessment -- 34. Medical Technologies: Involving Patients in Development and Assessment -- 35. Role of Patient Organisations -- 36. Discussion - Perspective of an HTA Appraisal Committee Chair -- 37. Reflections for Future Development.
Record Nr. UNINA-9910254652003321
Singapore : , : Springer Singapore : , : Imprint : Adis, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pharmacy Practice Research Methods / / edited by Zaheer-Ud-Din Babar
Pharmacy Practice Research Methods / / edited by Zaheer-Ud-Din Babar
Edizione [2nd ed. 2020.]
Pubbl/distr/stampa Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020
Descrizione fisica 1 online resource (271 pages)
Disciplina 615.1068
Soggetto topico Pharmacy management
Pharmacy
Practice of medicine
Pharmacoeconomics and Health Outcomes
Practice and Hospital Management
ISBN 981-15-2993-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1. Pharmacy Practice Research: Evidence, Impact and synthesis -- Chapter 2. Qualitative Methods in Pharmacy Practice Research -- Chapter 3. Action Research in Pharmacy Practice -- Chapter 4. Quality Improvement Methods in Pharmacy Practice Research -- Chapter 5. Covert and overt observations in Pharmacy practice -- Chapter 6. Realist Research in Pharmacy Practice -- Chapter 7. Importance of Mixed Methods Research in Pharmacy Practice -- Chapter 8. Grounded theory in pharmacy practice research -- Chapter 9. Pharmacoepidemiology and Pharmacoepidemiological research -- Chapter 10. Randomized Control Trials and pharmacy practice research -- Chapter 11. Information sources for pharmacy practice researchers -- Chapter 12. Systematic reviews and meta analysis in pharmacy practice research -- Chapter. 13. The future of pharmacy practice research.
Record Nr. UNINA-9910392734703321
Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pharmacy Practice Research Methods / / edited by Zaheer-Ud-Din Babar
Pharmacy Practice Research Methods / / edited by Zaheer-Ud-Din Babar
Edizione [1st ed. 2015.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015
Descrizione fisica 1 online resource (251 p.)
Disciplina 610
Soggetto topico Pharmacy management
Pharmacy
Pharmacoeconomics and Health Outcomes
ISBN 3-319-14672-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Pharmacy Practice Research- Evidence and Impact -- Research Methodologies related to pharmacy practice –An Overview -- Quantitative Methods in Pharmacy Practice Research -- Qualitative Methods in Pharmacy Practice Research -- Action Research in Pharmacy Practice -- Participatory Action Research in Pharmacy Practice -- Mixed Methods Research in Pharmacy Practice -- Applying organizational theory in Pharmacy Practice Research -- Applying pharmacoeconomic methods in community and hospital pharmacy research -- Concept Mapping and pattern matching in pharmacy practice research -- Pharmacoepidemiological approaches in healthcare -- Future of Pharmacy Practice Research -- Pharmacists’ attitudes towards pharmacy practice research: a review.
Record Nr. UNINA-9910300227303321
Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Reflux Aspiration and Lung Disease / / edited by Alyn H. Morice, Peter W. Dettmar
Reflux Aspiration and Lung Disease / / edited by Alyn H. Morice, Peter W. Dettmar
Edizione [1st ed. 2018.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018
Descrizione fisica 1 online resource (366 pages)
Disciplina 616.324
Soggetto topico Respiratory organs—Diseases
Gastroenterology 
Pharmacy management
Pneumology/Respiratory System
Gastroenterology
Pharmacoeconomics and Health Outcomes
ISBN 3-319-90525-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Part I: Overview and historical perspective -- History -- Reflux pathophysiology -- Pathophysiology in lung: what happens -- Chemical composition of reflux -- Pathological process -- Pepsin and bile -- Part II: Reflux in -- CF -- Bronchitis -- COPD -- Asthma -- Cough -- IPF -- Pneumonia and ITU -- Paediatrics -- Transplants -- Elderly -- Sleep -- pH impedance manometry and Restech -- Peptest -- Questionnaire -- Cough monitoring and the lung -- Radiology -- Lung function and challenge tests -- PPI pro/con -- Promotility, baclofen and lesogaberan -- Macrolides -- Inhalers, nebulisers and anti-inflammatories -- Speech therapy -- Surgical -- ENT, Airway reflux in otolaryngology.
Record Nr. UNINA-9910300441703321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Regulating Pharmaceutical Prices in India : Policy Design, Implementation and Compliance / / by Ajay Bhaskarabhatla
Regulating Pharmaceutical Prices in India : Policy Design, Implementation and Compliance / / by Ajay Bhaskarabhatla
Autore Bhaskarabhatla Ajay
Edizione [1st ed. 2018.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018
Descrizione fisica 1 online resource (IX, 306 p. 24 illus., 18 illus. in color.)
Disciplina 338.473621
Collana India Studies in Business and Economics
Soggetto topico Health economics
Globalization
Markets
Pharmacy management
Economic policy
Development economics
Health Economics
Emerging Markets/Globalization
Pharmacoeconomics and Health Outcomes
Economic Policy
Development Economics
ISBN 3-319-93393-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Introduction -- Part I. Historical Context and the Motivation for Regulation -- Brief History of Regulating Pharmaceutical Prices -- Is the 2013 Price Control Regulation Necessary? -- Part II. The Design of the 2013 DPCO Regulation -- The Proposed Design to Fix Ceiling Prices Under 2013 DPCO -- Challenges with Fixing the Ceiling Price Under the 2013 DPCO -- Part III. The Impact of the 2013 DPCO -- How Effective Are the 2013 DPCO Regulations? -- Firm Strategies to Mitigate the Impact of Price Control Regulation -- Part IV. Enforcement and Compliance -- Enforcement and Compliance with Price Ceilings on Essential Medicines -- Conclusion. .
Record Nr. UNINA-9910299642403321
Bhaskarabhatla Ajay  
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui